A single center, retrospective study assessing the Emicizumab prophylaxis for Hemophilia Α with and without Inhibitors
Latest Information Update: 04 Jan 2021
At a glance
- Drugs Emicizumab (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- 04 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology